Table 12.
S. No. | Treatment Type |
Endogenous Biomarkers |
||||
---|---|---|---|---|---|---|
Group Type | SOD (U/mg of protein) | NO (μg/mL) | LPO (nM/mg of protein) | Na+K+ATPase (μmol/mg of protein) | TNF-α (pg/mL) | |
1 | Normal Control | 27.13 ± 1.75 | 108.17 ± 2.62 | 2.59 ± 1.29 | 10.13 ± 1.46 | 53.48 ± 2.14 |
2 | Diabetic Control | 5.41 ± 1.34a | 306.12 ± 3.13a | 9.13 ± 1.26a | 2.77 ± 1.25a | 161.12 ± 2.32a |
3 | Standard | 16.14 ± 1.32∗ | 227.34 ± 2.35∗ | 6.26 ± 1.11∗ | 6.38 ± 1.25∗ | 120.21 ± 3.14∗ |
4 | Treated 1 | 21.35 ± 1.34∗ | 160.10 ± 4.49∗ | 4.21 ± 1.31∗ | 7.13 ± 4.19∗ | 91.18 ± 1.39∗ |
5 | Treated 2 | 25.28 ± 1.42∗ | 131.23 ± 5.11∗ | 2.91 ± 1.25∗ | 9.41 ± 2.51∗ | 69.43 ± 1.72∗ |
Values are expressed as Mean ± SEM; n = 6. One-way ANOVA; Tukey-Kramer multiple comparisons test: aP< 0.05 in comparison with normal control; ∗P < 0.05 in comparison with the diabetic control.